Growth Metrics

Inspire Medical Systems (INSP) Gross Profit (2017 - 2026)

Inspire Medical Systems' Gross Profit history spans 10 years, with the latest figure at $176.9 million for Q1 2026.

  • On a quarterly basis, Gross Profit rose 3.7% to $176.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $785.1 million, a 10.39% increase, with the full-year FY2025 number at $778.8 million, up 14.55% from a year prior.
  • Gross Profit hit $176.9 million in Q1 2026 for Inspire Medical Systems, down from $233.0 million in the prior quarter.
  • Over the last five years, Gross Profit for INSP hit a ceiling of $233.0 million in Q4 2025 and a floor of $59.4 million in Q1 2022.
  • Historically, Gross Profit has averaged $147.4 million across 5 years, with a median of $164.5 million in 2023.
  • Biggest five-year swings in Gross Profit: skyrocketed 81.9% in 2023 and later rose 3.7% in 2026.
  • Tracing INSP's Gross Profit over 5 years: stood at $115.7 million in 2022, then surged by 42.08% to $164.5 million in 2023, then rose by 23.88% to $203.7 million in 2024, then increased by 14.37% to $233.0 million in 2025, then decreased by 24.07% to $176.9 million in 2026.
  • Business Quant data shows Gross Profit for INSP at $176.9 million in Q1 2026, $233.0 million in Q4 2025, and $192.7 million in Q3 2025.